ASP Isotopes
Logotype for ASP Isotopes Inc

ASP Isotopes (ASPI) investor relations material

ASP Isotopes Emerging Growth Conference 97 summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for ASP Isotopes Inc
Emerging Growth Conference 97 summary28 Oct, 2026

Business strategy and technology

  • Four verticals span nuclear medicine, electronic gases, medical isotopes and nuclear energy; Quantum Leap Energy is expected to spin out and be separately listed on Nasdaq.

  • South African plants for carbon-14, silicon-28 and ytterbium-176 are built; silicon-28 is operational and progressing toward its first batch shipment.

  • ASP and laser-based quantum enrichment processes target isotope supply gaps; the speaker cited zero U.S. domestic production for the isotopes under consideration and Russia as a major supplier.

  • Noble Africa began liquid helium production; first commercial isotope shipments are targeted before year-end, with helium shipments planned for December and January.

Nuclear medicine and radiopharmacies

  • PET Labs supplies tens of thousands of nuclear medicine doses annually in South Africa; NuMed and East Coast Nuclear Pharmacy operate in the U.S.

  • Focus is on higher-value cancer-treatment isotopes, including ytterbium-176 feedstock for lutetium-177 used in Novartis’ PLUVICTO; estimated future global ytterbium and gadolinium market is $100m.

  • Global nuclear medicine market estimated at $33bn, radiopharmaceuticals at $13.5bn and commercial radiopharmacy at $6bn; market growth forecast at 8% from 2026 to 2031.

  • Plan to acquire and upgrade radiopharmacies with advanced production capabilities; target is about 10 locations in five years and 30 in 10 years.

Alpa Theranostics pipeline

  • Alpa’s VHH nanobody platform pairs diagnostic and therapeutic radioisotopes; first candidates are expected to enter patients later in 2026, with Phase I data expected in 2027.

  • Three assets are planned to enter clinical development within six to nine months; initial focus includes triple-negative breast cancer and osteosarcoma.

  • Phase I trials are planned in South Africa, with a first U.S. IND filing targeted for 2027; management said the South African path from concept to IND could take about two years.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next ASP Isotopes earnings date

Logotype for ASP Isotopes Inc
Q3 202627 Nov, 2026
ASP Isotopes
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next ASP Isotopes earnings date

Logotype for ASP Isotopes Inc
Q3 202627 Nov, 2026

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

ASP Isotopes Inc. is an advanced materials company that focuses on the development and production of isotopes for various industrial applications. The company leverages proprietary technology to produce and enrich isotopes that are used in nuclear medicine, therapeutics, green energy generation, and quantum computing. ASP Isotopes is particularly involved in the commercialization of isotopes like Molybdenum-100, Carbon-14, and Silicon-28. The company also explores the development of Quantum Enrichment technology to produce other isotopes, such as Ytterbium-176, Nickel-64, and Uranium-235. Incorporated in 2021, ASP Isotopes operates facilities in South Africa and is headquartered in Washington, D.C. Its shares are traded on the NASDAQ.